Changes in T-cell subsets and clonal repertoire during chemoimmunotherapy with pembrolizumab and paclitaxel or capecitabine for metastatic triple-negative breast cancer

• William L Redmond,
• David B Page,
• Walter J Urba,
• Heather L McArthur,
• Yoshinobu Koguchi,
• Valerie Conrad,
• Nathan Polaske,
• ShuChing Chang,
• Venkatesh Rajamanickam,
• Brady Bernard,
• Isaac Kim,
• Brie Chun,
• Joanna Pucilowska,
• Benjamin Nikitin,
• Mark Schmidt,
• Paul A Fields,
• Alison K Conlin

Affiliations

William L Redmond

Earle A Chiles Research Institute, Providence Cancer Institute, Portland, Oregon, USA

David B Page

Earle A Chiles Research Institute, Providence Cancer Institute, Portland, Oregon, USA

Walter J Urba

Earle A Chiles Research Institute, Providence Cancer Institute, Portland, Oregon, USA

Heather L McArthur

Department of Medicine, University of Texas Southwestern Medical Center, Dallas, Texas, USA

Yoshinobu Koguchi

Earle A Chiles Research Institute, Providence Cancer Institute, Portland, Oregon, USA

Valerie Conrad

Earle A Chiles Research Institute, Providence Cancer Institute, Portland, Oregon, USA

Nathan Polaske

Adaptive Biotechnologies Corp, Seattle, Washington, USA

ShuChing Chang

Medical Data Research Center, Providence St Joseph Health, Portland, Oregon, USA

Venkatesh Rajamanickam

Earle A Chiles Research Institute, Providence Cancer Institute, Portland, Oregon, USA

Brady Bernard

Earle A Chiles Research Institute, Providence Cancer Institute, Portland, Oregon, USA

Isaac Kim

Earle A Chiles Research Institute, Providence Cancer Institute, Portland, Oregon, USA

Brie Chun

Earle A Chiles Research Institute, Providence Cancer Institute, Portland, Oregon, USA

Joanna Pucilowska

Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon, USA

Benjamin Nikitin

Earle A Chiles Research Institute, Providence Cancer Institute, Portland, Oregon, USA

Mark Schmidt

Earle A Chiles Research Institute, Providence Cancer Institute, Portland, Oregon, USA

Paul A Fields

Adaptive Biotechnologies Corp, Seattle, Washington, USA

Alison K Conlin

Earle A Chiles Research Institute, Providence Cancer Institute, Portland, Oregon, USA